Literature DB >> 20659689

Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains.

Catarina R Vieira1, Jose M Munoz-Olaya, Jesús Sot, Sonia Jiménez-Baranda, Nuria Izquierdo-Useros, Jose Luis Abad, Beatriz Apellániz, Rafael Delgado, Javier Martinez-Picado, Alicia Alonso, Josefina Casas, José L Nieva, Gemma Fabriás, Santos Mañes, Félix M Goñi.   

Abstract

The lateral organization of lipids in cell membranes is thought to regulate numerous cell processes. Most studies focus on the coexistence of two fluid phases, the liquid crystalline (l(d)) and the liquid-ordered (l(o)); the putative presence of gel domains (s(o)) is not usually taken into account. We show that in phospholipid:sphingolipid:cholesterol mixtures, in which sphingomyelin (SM) promoted fluid l(o) domains, dihydrosphingomyelin (DHSM) tended to form rigid domains. Genetic and pharmacological blockade of the dihydroceramide desaturase (Des1), which replaced SM with DHSM in cultured cells, inhibited cell infection by replication-competent and -deficient HIV-1. Increased DHSM levels gave rise to more rigid membranes, resistant to the insertion of the gp41 fusion peptide, thus inhibiting viral-cell membrane fusion. These results clarify the function of dihydrosphingolipids in biological membranes and identify Des1 as a potential target in HIV-1 infection. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659689     DOI: 10.1016/j.chembiol.2010.05.023

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  23 in total

1.  Cell density-dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells.

Authors:  Stefka D Spassieva; Mehrdad Rahmaniyan; Jacek Bielawski; Christopher J Clarke; Jacqueline M Kraveka; Lina M Obeid
Journal:  J Lipid Res       Date:  2012-02-29       Impact factor: 5.922

Review 2.  Roles for biological membranes in regulating human immunodeficiency virus replication and progress in the development of HIV therapeutics that target lipid metabolism.

Authors:  Norman J Haughey; Luis B Tovar-y-Romo; Veera Venkata Ratnam Bandaru
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-29       Impact factor: 4.147

3.  Gel domains in the plasma membrane of Saccharomyces cerevisiae: highly ordered, ergosterol-free, and sphingolipid-enriched lipid rafts.

Authors:  Francisco Aresta-Branco; André M Cordeiro; H Susana Marinho; Luísa Cyrne; Fernando Antunes; Rodrigo F M de Almeida
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

Review 4.  Dihydroceramides: From Bit Players to Lead Actors.

Authors:  Monowarul Mobin Siddique; Ying Li; Bhagirath Chaurasia; Vincent A Kaddai; Scott A Summers
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

5.  Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion.

Authors:  Yasuhiro Hayashi; Yoko Nemoto-Sasaki; Takashi Tanikawa; Saori Oka; Kiyoto Tsuchiya; Kouta Zama; Susumu Mitsutake; Takayuki Sugiura; Atsushi Yamashita
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

6.  Could the Ebola virus matrix protein VP40 be a drug target?

Authors:  Robert V Stahelin
Journal:  Expert Opin Ther Targets       Date:  2013-11-28       Impact factor: 6.902

Review 7.  HIV entry and envelope glycoprotein-mediated fusion.

Authors:  Robert Blumenthal; Stewart Durell; Mathias Viard
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

8.  Dihydroceramide Desaturase 1 Inhibitors Reduce Amyloid-β Levels in Primary Neurons from an Alzheimer's Disease Transgenic Model.

Authors:  Lara Ordóñez-Gutiérrez; Irene Benito-Cuesta; José Luis Abad; Josefina Casas; Gemma Fábrias; Francisco Wandosell
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

9.  Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization.

Authors:  Mara Leimanis-Laurens; Emily Wolfrum; Karen Ferguson; Jocelyn R Grunwell; Dominic Sanfilippo; Jeremy W Prokop; Todd A Lydic; Surender Rajasekaran
Journal:  J Pers Med       Date:  2021-04-24

10.  Ablation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitro.

Authors:  Monowarul M Siddique; Benjamin T Bikman; Liping Wang; Li Ying; Erin Reinhardt; Guanghou Shui; Markus R Wenk; Scott A Summers
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.